comparemela.com

Latest Breaking News On - Drug resistant epilepsy - Page 5 : comparemela.com

LivaNova PLC: LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) Annual Meeting taking place December 3

United statesCity ofUnited kingdomPaul buckmanDeanna wilkeLu zhangRyans vernerReginald lassagneRoberth lurieGaia giannicolaMaxine dibuSpecialized centers around the worldAmerican epilepsy societyCorporate communicationsDivision of pediatric neurosurgeryNeuromodulation medical affairs

MGC Pharma secures $10m capital raise from US and UK investors to advance development for its lead drug candidate, CimetrA

MGC Pharma secures $10m capital raise from US and UK investors to advance development for its lead drug candidate, CimetrA
stockhead.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stockhead.com.au Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCity ofRoby zomerUnited kingdom stockbrokerTurner pope investmentsEastern europeSwiss pharmacanLondon stockDrug resistant epilepsyMalta enterpriseCimetra production facility

Epilepsy Pipeline Analysis: 70+ Key Pipeline Therapies and 70+ Key Pharma Players are Looking Out in the Epilepsy Pipeline Landscape

Epilepsy Pipeline Analysis: 70+ Key Pipeline Therapies and 70+ Key Pharma Players are Looking Out in the Epilepsy Pipeline Landscape

United statesSandeep joshiAmryt pharmaUniversity collaborations licensing partnering analysisCerecor incMarinus pharmaceuticalsResearch newswireCerebral therapeuticsOtsuka pharmaceutical co ltdGanaxolone marinus pharmaceuticalsEuropean commissionDrug administrationEpilepsy key companiesLenus therapeuticsEpilepsy companyOtsuka pharmaceutical co

Epilepsy Pipeline Analysis: 70+ Key Pipeline Therapies and 70+ Key Pharma Players are Looking Out in the Epilepsy Pipeline Landscape

Epilepsy Pipeline Analysis: 70+ Key Pipeline Therapies and 70+ Key Pharma Players are Looking Out in the Epilepsy Pipeline Landscape

United statesSandeep joshiAmryt pharmaUniversity collaborations licensing partnering analysisCerecor incMarinus pharmaceuticalsResearch newswireCerebral therapeuticsOtsuka pharmaceutical co ltdGanaxolone marinus pharmaceuticalsEuropean commissionDrug administrationEpilepsy key companiesLenus therapeuticsEpilepsy companyOtsuka pharmaceutical co

Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: Landmark UK Import Permit granted for CannEpil+

Investegate |MGC Pharmaceuticals Announcements | MGC Pharmaceuticals: Landmark UK Import Permit granted for CannEpil+
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomGavin sathianathanTurner popeTmand cannepilRoby zomerCharles vivian tim pearsonAndy thackerDavid limRegulatory agencyPharmaceuticals ltdGrowth ltdMgc pharmaceuticals ltdUnited kingdom import permitRefractory epilepsyClinical trial

vimarsana © 2020. All Rights Reserved.